RUNX2 Polyclonal Antibody

• Host:

  Rabbit

• Immunogen:

  Synthesized peptide derived from the Internal region of human RUNX2.

• Target:

  Acute myeloid leukemia 3 protein; Alpha subunit 1; AML3; CBF alpha 1; CBF-alpha-1; CBFA1; CCD; CCD1; Cleidocranial dysplasia 1; Core binding factor; Core binding factor runt domain alpha subunit 1; Core binding factor subunit alpha 1; Core-binding factor subunit alpha-1; MGC120022; MGC120023; Oncogene AML 3; Oncogene AML-3; OSF 2; OSF-2; OSF2; Osteoblast specific transcription factor 2; Osteoblast-specific transcription factor 2; OTTHUMP00000016533; PEA2 alpha A; PEA2-alpha A; PEA2aA; PEBP2 alpha A; PEBP2-alpha A; PEBP2A1; PEBP2A2; PEBP2aA; PEBP2aA1; Polyomavirus enhancer binding protein 2 alpha A subunit; Polyomavirus enhancer-binding protein 2 alpha A subunit; Runt domain; Runt related transcription factor 2; Runt-related transcription factor 2; RUNX2; RUNX2; SL3 3 enhancer factor 1 alpha A subunit; SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core binding factor alpha A subunit; SL3/AKV core-binding factor alpha A subunit

• Clonality:

  Polyclonal

• Purification Method:

  Affinity purification

• Dilution:

  WB 1:500 - 1:2000; IF 1:50 - 1:200

• Storage Conditions:

  Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

• Fragment:

  IgG

• Citation 01:

  https://www.sciencedirect.com/science/article/pii/s0006295222003781

• Citation 02:

  https://onlinelibrary.wiley.com/doi/abs/10.1111/jre.12973

• Citation 03:

  https://onlinelibrary.wiley.com/doi/abs/10.1111/odi.14218